543 Results

People

  1. Schoder
    Schoder
  2. Humm
    Humm
  3. Zelenetz
    Zelenetz
  4. Lee
    Lee
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Larson
    Larson
  8. Palomba
    Palomba
  9. Yahalom
    Yahalom
  10. Horwitz
    Horwitz

Groups

  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)
  7. Survivorship Research (147)
  8. Center for Hematologic Malignancies (146)
  9. Epidemiology and Biostatistics (144)
  10. Medical Physics (144)
  1. "Heiko Schoder"
Formats
  1. Journal Article (263)
  2. Meeting Abstract (199)
  3. Book Section (31)
  4. Review (18)
  5. Editorial (14)
  6. Guidelines (8)
  7. Research Letter (6)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)

More Groups

People
  1. Heiko Schoder (543)
  2. John Humm (96)
  3. Steven Larson (93)
  4. Andrew Zelenetz (66)
  5. Nancy Lee (65)
  6. Alison Moskowitz (59)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (42)
  4. 2022 (40)
  5. 2021 (51)
  6. 2020 (30)

More Years

Publications
  1. Journal of Nuclear Medicine (94)
  2. Journal of Clinical Oncology (60)
  3. Blood (59)
  4. International Journal of Radiation Oncology, Biology, Physics (41)
  5. European Journal of Nuclear Medicine and Molecular Imaging (38)
  6. Hematological Oncology (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (94)
  2. Springer (78)
  3. Elsevier Inc. (67)
  4. American Society of Hematology (65)
  5. American Society of Clinical Oncology (60)
  6. Lippincott Williams & Wilkins (22)

More Publishers

Results (543)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)
    Journal Article

    Smith, S. M.; Schoder, H.; Johnson, J. L.; Jung, S. H.; Bartlett, N. L.; Cheson, B. D.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma
    Journal Article

    Sherman, E. J.; Su, Y. B.; Lyall, A.; Schoder, H.; Fury, M. G.; Ghossein, R. A.; Haque, S.; Lisa, D.; Shaha, A. R.; Tuttle, R. M.; more...
    Thyroid (2013)

    Fulltext@MSK | Save
  • Split-dose technique for FDG PET/CT-guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
    Journal Article

    Ryan, E. R.; Sofocleous, C. T.; Schoder, H.; Carrasquillo, J. A.; Nehmeh, S.; Larson, S. M.; Thornton, R.; Siegelbaum, R. H.; Erinjeri, J. P.; Solomon, S. B.
    Radiology (2013)

    Fulltext@MSK | Save
  • Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer
    Journal Article

    Goenka, A.; Morris, L. G. T.; Rao, S. S.; Wolden, S. L.; Wong, R. J.; Kraus, D. H.; Ohri, N.; Setton, J.; Lok, B. H.; Riaz, N.; more...
    International Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Reporting guidance for oncologic 18F-FDG PET/CT imaging
    Journal Article

    Niederkohr, R. D.; Greenspan, B. S.; Prior, J. O.; Schoder, H.; Seltzer, M. A.; Zukotynski, K. A.; Rohren, E. M.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration
    Journal Article

    Burger, I. A.; Vargas, H. A.; Donati, O. F.; Andikyan, V.; Sala, E.; Gonen, M.; Goldman, D. A.; Chi, D. S.; Schoder, H.; Hricak, H.
    Gynecologic Oncology (2013)

    Fulltext@MSK | Save
  • ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma
    Journal Article

    Hartridge-Lambert, S. K.; Schoder, H.; Lim, R. C.; Maragulia, J. C.; Portlock, C. S.
    Cancer (2013)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comparison of PSA, FDG-PET, and Prostate Cancer Working Group 2 (PCWG2) criteria to interpret apparent progression on first post-treatment bone scan
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Haupt, E. C.; Schoder, H.; Scher, H. I.; Larson, S. M.; Morris, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of dual tracer (FLT and FDG) PET imaging as part of risk-adapted therapy for patients with advanced stage diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P.; Maragulia, J. C.; Walkley, J.; Zelenetz, A. D.
    Blood (2012)

    Fulltext@MSK | Save